Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway
Advise patients to seek urgent medical attention if these occur
Nonetheless, other phases are also affected
Hypersensitivity, such as hives (urticaria) Respiratory Side Effects (particularly when used inhaled/nebulized): Chest tightness Bronchoconstriction (airway narrowing) Irritation of the bronchi or the trachea
The margin for error is significant, especially at lower doses where small volume differences translate to large percentage changes in the delivered dose
US$ 20.75
US$ 23.57
US$ 24.29
